We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

Shares of GSK PLC GSK inched up 0.78% to £13.59 Friday, on what proved to be an all-around great trading session for the ...

On Monday, GSK plc (GSK) stock saw a decline, ending the day at $32.7 which represents a decrease of $-0.39 or -1.18% from the prior close of $33.09. The stock opened at $32.74 and touched a low of ...

Shares of GSK PLC GSK advanced 1.58% to £13.49 Thursday, on what proved to be an all-around favorable trading session for the ...

The investment seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of GSK plc in its local market. The series, under ...

ST Germain D J Co. Inc. increased its stake in GSK plc (NYSE:GSK – Free Report) by 195.5% during the fourth quarter, ...

GSK plc (GSK) stock saw a decline, ending the day at $33.09 which represents a decrease of $-0.66 or -1.96% from the prior close of $33.75. The stock opened at $33.26 and touched a low of $33.01 ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) Monday announced that it has signed an agreement to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company, for up to $1.15 billion ...

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...